Publication Name	World Journal of Clinical Cases
Manuscript ID	95811
Country	China

Received	2024-04-19 04:04
Peer-Review Started	2024-04-19 04:04
To Make the First Decision
Return for Revision	2024-06-18 03:43
Revised	2024-06-22 07:54
Second Decision	2024-06-28 02:50
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-06-28 09:51
Articles in Press	2024-06-28 09:51
Publication Fee Transferred	2024-07-01 08:07
Edit the Manuscript by Language Editor	2024-07-10 01:16
Typeset the Manuscript	2024-07-12 02:07
Publish the Manuscript Online	2024-07-17 05:55

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	Returning from the afterlife? Sotorasib treatment for advanced KRAS mutant lung cancer: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Ming-Xing Wang, Pei Zhu, Yue Shi, Qing-Ming Sun and Wan-Hui Dong
ORCID	Author(s) ORCID Number Wan-Hui Dong http://orcid.org/0000-0002-6470-4643
Funding Agency and Grant Number
Corresponding Author	Wan-Hui Dong, MD, Chief Doctor, Department of Medical Oncology, Lu'an Hospital of Traditional Chinese Medicine, No. 76 Renmin Road, Lu'an 237000, Anhui Province, China. dongwanhui@laszyy.cn
Key Words	Non-small cell lung cancer; Sotorasib; KRAS G12C; Targeted therapy; Advanced carcinoma; Case report
Core Tip	In this study, we demonstrate the efficacy of Sotorasib in treating advanced non-small cell lung cancer with the KRAS G12C mutation. A patient diagnosed with stage IVB adenocarcinoma, exhibiting pelvic and bone metastases, showed a significant improvement in clinical symptoms post-Sotorasib treatment, with no severe side effects observed. This case highlights the potential of targeted therapies in personalized cancer treatment, emphasizing the importance of genomic profiling for therapeutic decision-making.
Publish Date	2024-07-17 05:55
Citation	<p>Wang MX, Zhu P, Shi Y, Sun QM, Dong WH. Returning from the afterlife? Sotorasib treatment for advanced KRAS mutant lung cancer: A case report. <i>World J Clin Cases</i> 2024; 12(25): 5805-5813</p>
URL	https://www.wjgnet.com/2307-8960/full/v12/i25/5805.htm
DOI	https://dx.doi.org/10.12998/wjcc.v12.i25.5805

Full Article (PDF)	WJCC-12-5805-with-cover.pdf
CARE Checklist–2016	95811-CARE-Checklist-2016.pdf
Manuscript File	95811_Auto_Edited_072536.docx
Answering Reviewers	95811-answering-reviewers.pdf
Audio Core Tip	95811-audio.mp3
Conflict-of-Interest Disclosure Form	95811-conflict-of-interest-statement.pdf
Copyright License Agreement	95811-copyright-assignment.pdf
Signed Consent for Treatment Form(s) or Document(s)	95811-informed-consent-statement.pdf
Non-Native Speakers of English Editing Certificate	95811-non-native-speakers.pdf
Peer-review Report	95811-peer-reviews.pdf
Scientific Misconduct Check	95811-scientific-misconduct-check.png
Scientific Editor Work List	95811-scientific-editor-work-list.pdf
CrossCheck Report	95811-crosscheck-report.pdf
CrossCheck Report	95811-crosscheck-report.png